Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 20, 2008 - Issue 3
260
Views
41
CrossRef citations to date
0
Altmetric
Research Article

Decreased Airway Expression of Vascular Endothelial Growth Factor in Cigarette Smoke-Induced Emphysema in Mice and COPD Patients

, , , , , , , , , & show all
Pages 349-359 | Received 03 Sep 2007, Accepted 18 Oct 2007, Published online: 06 Oct 2008

REFERENCES

  • Bartalesi B., Cavarra E., Fineschi S., Lucattelli M., Lunghi B., Martorana P. A., Lungarella G. Diffrernt lung responses to cigarette smoke in two strains of mice sensitive to oxidants. Eur. Respir. J. 2005; 25: 15–22
  • Berse B., Brown L. F., Van de Water L., Dvorak H. F., Senger D. R. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differently in normal tissues, macrophages, and tumors. Mol. Biol. Cell 1992; 2: 211–220
  • Betsuyaku T., Senior R. M. Laser capture microdissection and mRNA characterization of mouse airway epithelium: Methodological considerations. Micron 2004; 35: 229–234
  • Betsuyaku T., Griffin G. L., Watson M. A., Senior R. M. Laser capture microdissection and real-time reverse transcriptase/polymerase chain reaction of bronchiolar epithelium after bleomycin. Am. J. Respir. Cell Mol. Biol. 2001; 25: 278–284
  • Betsuyaku T., Fuke S., Nasuhara Y., Morikawa T., Kondo S., Nishimura M. Diverse Expression of antioxidants and inflammatory chemokines in terminal bronchiolar epithelium in chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2006; 3: 471–472
  • Brown K. R., England K. M., Goss K. L., Snyder J. M., Acarregui M. J. VEGF induces airway epithelial cell proliferation in human fetal lung in vitro. Am. J. Physiol. Lung Cell Mol. 2001; 281: L1001–L1010
  • de Boer W. I., Sont J. K., van Schadewijk A., Stolk J., van Krieken J. H., Hiemstra P. S. Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD. J. Pathol. 2000; 190: 619–626
  • Dhar P. Measuring tobacco smoke exposure: quantifying nicotine/cotinine concentration in biological samples by colorimetry, chromatography and immunoassay methods. J. Pharm. Biomed. Anal. 2004; 35: 155–168
  • Fabbri L., Pauwels R. A., Hurd S. S. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD executive summary updated 2003. J. COPD 2004; 1: 105–141
  • Fehrenbach H., Kasper M., Haase M., Schuh D., Muller M. Differential immunolocalization of VEGF in rat and human adult lung, and in experimental rat lung fibrosis: light, fluorescence, and electron microscopy. Anat. Rec. 1999; 254: 61–73
  • Ferrara N., Gerber H. P., LeCouter J. The biology of VEGF and its receptors. Nat. Med. 2003; 9: 669–676
  • Foster R. R., Hole R., Anderson K., Satchell S. C., Coward R. J., Mathieson P. W., Gillatt D. A., Saleem M. A., Bates D. O., Harper S. J. Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes. Am. J. Physiol. Renal. Physiol. 2003; 284: F1263–F1273
  • Fuke S., Betsuyaku T., Nasuhara Y., Morikawa T., Katoh H., Nishimura M. Chemokines in bronchiolar epithelium in the development of chronic obstructive pulmonary disease. Am. J. Respir. Cell Mol. Biol. 2004; 31: 405–412
  • Han M. K., Postma D., Mannino D., Giardino N. D., Buist S., Curtis J. L., Martinez F. J. Gender and COPD: Why it matters. Am. J. Respir. Crit. Care Med. 2007; 176: 1179–1184
  • Hogg J. C., Macklem P. T., Thurlbeck W. M. Site and nature of airway obstruction in chronic obstructive lung disease. N. Engl. J. Med. 1968; 278: 1355–1360
  • Hogg J. C., Chu F., Utokaparch S., Woods R., Elliott W. M., Buzatu L., Cherniack R. M., Rogers R. M., Sciurba F. C., Coxson H. O., Pare P. D. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 2004; 350: 2645–2653
  • Jarvis M. J., Primatesta P., Erens B., Feyerabend C., Bryant A. Measuring nicotine intake in population surveys: comparability of saliva cotinine and plasma cotinine estimates. Nicotine Tobacco Res. 2003; 5: 349–355
  • Kanazawa H., Asai K., Hirata K., Yoshikawa J. Possible effects of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease. Am. J. Med. 2003; 114: 354–358
  • Kasahara Y., Tuder R. M., Taraseviciene-Stewart L., Le Cras T. D., Abman S., Hirsh P. K., Waltenberger J., Voelkel N. F. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J. Clin. Invest. 2000; 106: 1311–1319
  • Kasahara Y., Tuder R. M., Cool C. D., Lynch D. A., Flores S. C., Voelkel N. F. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am. J. Respir. Crit. Care Med. 2001; 163: 737–744
  • Kim C. F., Jackson E. L., Woolfenden A. E., Lawrence S., Babar I., Vogel S., Crowley D., Bronson R. T., Jacks T. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005; 121: 823–835
  • Koyama S., Sato E., Haniuda M., Numanami H., Nagai S., Izumi T. Decerased level of vascular endothelial growth factor in bronchoalveolar lavage fluid of normal smokers and patients with pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2002a; 166: 382–385
  • Koyama S., Sato E., Haniuda M., Numanami H., Kurai M., Nagai S., Izumi T. Vascular endothelial growth factor mRNA and protein expression in airway epithelial cell lines in vitro. Eur. Respir. J. 2002b; 20: 1449–1456
  • Kranenburg A. R., de Boer W. I., Alagappan V. K. T., Sterk P. J., Sharma H. S. Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease. Thorax 2005; 60: 106–113
  • Marwick J. A., Stevenson C. S., Giddings J., MacNee W., Butler K., Rahman I., Kirkham P. A. Cigarette smoke disrupts the VEGF165-VEGFR2 receptor signaling complex in rat lungs and patients with COPD: Morphological impact of VEGFR2 inhibition. Am. J. Phisiol. Lung Cell Mol. Physiol. 2006; 290: 897–908
  • Mura M., Han B., Andrade C. F., Seth R., Hwang D., Waddell T. K., Keshavjee S., Liu M. The early responses of VEGF and its receptors during acute lung injury: Implication of VEGF in alveolar epithelial cell survival. Crit. Care 2006; 10: R130
  • Nagai K., Betsuyaku T., Ito Y., Nasuhara Y., Nishimura M. Decrease of vascular endothelial growth factor in macrophages from long-term smokers. Eur. Respir. J. 2005; 25: 626–633
  • Obot C., Lee K., Fuciarelli A., Renne R., McKinney W. Charactereization of mainstream cigarette smoke-induced biomarker responsed in ICR and C57Bl/6 mice. Inhal. Toxicol. 2004; 16: 701–719
  • Pauwels R. A., Buist A. S., Calverley P. M., Jenkins C. R., Hurd S. S., GOLD Science Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am. J. Respir. Crit. Care Med. 2001; 163: 1256–1276
  • Pauwels R. A., Rabe K. F. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004; 364: 613–620
  • Plopper C. G. Clara cells. Lung growth and development. Lung biology in health and disease, J. A. McDonald. Marcel Dekker, New York 1997; 181–209
  • Rahman I. Oxidative stress in pathogenesis of chronic obstructive pulmonoary disease: Cellular and molecular mechanisms. Cell Biochem. Biophys. 2005; 43: 167–188
  • Rovina N., Papapetropoulos A., Kollintza A., Michailidou M., Simoes D. C., Roussos C., Gratziou C. Vascular endothelial growth factor: An angiogenic factor reflecting airway inflammation in healthy smokers and in patients with bronchitis type of chronic obstructive pulmonary disease?. Respir. Res. 2007; 8: 53
  • Takubo Y., Guerassimov A., Ghezzo H., Triantafillopoulos A., Bates J. H., Hoidal J. R., Cosio M. G. Alpha1-antitrypsin determines the pattern of emphysema and function in tobacco smoke-exposed mice: Parallels with human disease. Am. J. Respir. Crit. Care Med. 2002; 166: 1596–1603
  • Tang K., Rossiter H. B., Wagner P. D., Breen E. C. Lung-targeted VEGF inactivation leads to an emphysema phenotype in mice. J. Appl. Physiol. 2004; 97: 1559–1566
  • Thurlbeck W. M. Internal surface area and other measurements in emphysema. Thorax 1967; 22: 483–496
  • Vial W. C. Cigarette smoking and lung disease. Am. J. Med. Sci. 1986; 291: 130–142
  • Voelkel N. F., Vandivier W. V., Tuder R. M. Vascular endothelial growth factor in the lung. Am. J. Phisiol. Lung Cell Mol. Physiol. 2006; 290: 209–221
  • Waltenberger J., Claesson-Welsh L., Siegbahn A., Shibuya M., Heldin C. H. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J. Biol. Chem. 1994; 269: 26988–26995
  • Yanai M., Sekizawa K., Ohrui T., Sasaki H., Takishima T. Site of airway obstruction in pulmonary disease: Direct measurement of intrabronchial pressure. J. Appl. Physiol. 1992; 72: 1016–1023

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.